Metabolic pathways enriched according to ERG status are associated with biochemical recurrence in Hispanic/Latino patients with prostate cancer
Open Access
- 3 November 2022
- journal article
- research article
- Published by Wiley in Cancer Medicine
- Vol. 12 (4) , 4306-4320
Abstract
Background: The role of ERG‐status molecular subtyping in prognosis of prostate cancer (PCa) is still under debate. In this study, we identified differentially expressed genes (DEGs) according to ERG‐status to explore their enriched pathways and implications in prognosis in Hispanic/Latino PCa patients.Methods: RNA from 78 Hispanic PCa tissues from radical prostatectomies (RP) were used for RNA‐sequencing. ERGhigh/ERGlow tumor groups were determined based on the 1.5‐fold change median expression in non‐tumor samples. DEGs with a False Discovery Rate (FDR) < 0.01 and a fold change >2 were identified between ERGhigh and ERGlow tumors and submitted to enrichment analysis in MetaCore. Survival and association analyses were performed to evaluate biochemical recurrence (BCR)‐free survival.Results: The identification of 150 DEGs between ERGhigh and ERGlow tumors revealed clustering of most of the non‐BCR cases (60%) into de ERGhigh group and most of the BCR cases (60.8%) in ERGlow group. Kaplan–Meier survival curves showed a worst BCR‐free survival for ERGlow patients, and a significant reduced risk of BCR was observed for ERGhigh cases (OR = 0.29 (95%CI, 0.10–0.8)). Enrichment pathway analysis identified metabolic‐related pathways, such as the renin‐angiotensin system and angiotensin maturation system, the linoleic acid metabolism, and polyamines metabolism in these ERG groups.Conclusions: ERGlow tumor cases were associated with poor BCR‐free survival in our Hispanic/Latino patients, with metabolism‐related pathways altered in the BCR progression.Impact: Our findings suggest the need to dissect the role of diet, metabolism, and lifestyle as risk factors for more aggressive PCa subtypes.Keywords
Funding Information
- Instituto Nacional de Cancerología (Project funding C41030310118 by MCSS, project funding C19010300456 by ALC)
This publication has 71 references indexed in Scilit:
- Effect of n-3 and n-6 unsaturated fatty acids on prostate cancer (PC-3) and prostate epithelial (RWPE-1) cells in vitroLipids in Health and Disease, 2013
- Spermine and Citrate as Metabolic Biomarkers for Assessing Prostate Cancer AggressivenessPLOS ONE, 2013
- Distinct ERG rearrangement prevalence in prostate cancer: higher frequency in young age and in low PSA prostate cancerProstate Cancer and Prostatic Diseases, 2013
- Current Evidence Linking Polyunsaturated Fatty Acids with Cancer Risk and ProgressionFrontiers in Oncology, 2013
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- The influence of race and ethnicity on the biology of cancerNature Reviews Cancer, 2012
- RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genomeBMC Bioinformatics, 2011
- TMPRSS2–ERG gene fusion is associated with low Gleason scores and not with high-grade morphological featuresLaboratory Investigation, 2010
- Genetic Ancestry and Risk of Breast Cancer among U.S. LatinasCancer Research, 2008
- Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate CancerScience, 2005